Open AccessRole of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach
Author(s) -
Vivencio Barrios,
Sergio CinzaSanjurjo,
Javier GarcíaAlegría,
Román Freixa-Pamias,
Frederic Llordachs-Marques,
Carlos A. Molina,
A. Santamaría,
David Vivas,
Carmen Suárez Fernández
Publication year - 2022
Publication title -
future cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.392
H-Index - 33
eISSN - 1744-8298
pISSN - 1479-6678
DOI - 10.2217/fca-2022-0044
Subject(s) - medicine , telemedicine , atrial fibrillation , multidisciplinary approach , intensive care medicine , management of atrial fibrillation , health care , medical emergency , population , cardiology , social science , environmental health , sociology , economics , economic growth
Compared with face-to-face consultations, telemedicine has many advantages, including more efficient use of healthcare resources, partial relief of the burden of care, reduced exposure to COVID-19, treatment adjustment, organization of more efficient healthcare circuits and patient empowerment. Ensuring optimal anticoagulation in atrial fibrillation patients is mandatory if we want to reduce the thromboembolic risk. Of note, telemedicine is an excellent option for the long-term management of atrial fibrillation patients. Moreover, direct oral anticoagulants may provide an added value in telemedicine (versus vitamin K antagonists), as it is not necessary to monitor anticoagulant effect or make continuous dosage adjustments. In this multidisciplinary consensus document, the role of telemedicine in anticoagulation of this population is discussed and practical recommendations are provided.